APA (7th ed.) Citation

Gentinetta, T., Belcher, J. D., Brügger-Verdon, V., Adam, J., Ruthsatz, T., Bain, J., . . . Martin, K. (2022). Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence. Journal of Clinical Medicine, 11(3), 630. https://doi.org/10.3390/jcm11030630

Chicago Style (17th ed.) Citation

Gentinetta, Thomas, et al. "Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence." Journal of Clinical Medicine 11, no. 3 (2022): 630. https://doi.org/10.3390/jcm11030630.

MLA (9th ed.) Citation

Gentinetta, Thomas, et al. "Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence." Journal of Clinical Medicine, vol. 11, no. 3, 2022, p. 630, https://doi.org/10.3390/jcm11030630.